Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.8%

1 terminated/withdrawn out of 132 trials

Success Rate

97.0%

+10.5% vs industry average

Late-Stage Pipeline

14%

19 trials in Phase 3/4

Results Transparency

3%

1 of 32 completed trials have results

Key Signals

28 recruiting1 with results

Enrollment Performance

Analytics

N/A
44(58.7%)
Phase 4
11(14.7%)
Phase 2
9(12.0%)
Phase 3
8(10.7%)
Early Phase 1
3(4.0%)
75Total
N/A(44)
Phase 4(11)
Phase 2(9)
Phase 3(8)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (132)

Showing 20 of 132 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT04909697Phase 4Completed

Treatment of ARDS With Sivelestat Sodium

Role: lead

NCT04078568Phase 3Completed

Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

Role: collaborator

NCT06681948Not ApplicableCompleted

The Ketogenic Diet in the Treatment of Alzheimer's Disease

Role: collaborator

NCT07471022Completed

Hemiarthroplasty for Elderly With Proximal Humeral Mets

Role: lead

NCT07382921Not ApplicableNot Yet Recruiting

Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia

Role: collaborator

NCT06853535Phase 3Recruiting

Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE

Role: lead

NCT07349498Recruiting

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT06676007Recruiting

A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy

Role: lead

NCT07336927Not ApplicableNot Yet Recruiting

IAT-MeVO Trial Domain Within the ACT-GLOBAL Adaptive Platform Trial

Role: collaborator

NCT07343102Completed

Incidence of Hemocompatibility Events With or Without Aspirin in Patients With CH-VAD

Role: collaborator

NCT07340437Completed

Clinical Study of 18F-Exendin-4 in Insulinoma

Role: lead

NCT07298525Phase 4Not Yet Recruiting

Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monitoring Settings

Role: lead

NCT07298616Phase 3Recruiting

Huaxi Tunnel Technique For Recurrent Laryngeal Nerve Exposure And Dissection In Thyroid Surgery

Role: collaborator

NCT06636279Not ApplicableCompleted

A Randomized Study of Gas Bubble Technique in Cataract Surgery

Role: lead

NCT05770661Recruiting

China Axial Length Study

Role: collaborator

NCT05631847Not ApplicableCompleted

Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

Role: collaborator

NCT07179653Phase 2Active Not Recruiting

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients

Role: collaborator

NCT07175363Not Yet Recruiting

Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study

Role: lead

NCT07176754Not ApplicableNot Yet Recruiting

TNF-α Antagonists Mitigate Systemic Inflammatory Response After Cardiac Arrest.

Role: collaborator